(...) Denmark, Norway and Iceland have temporarily suspended the use of AstraZeneca's Covid-19 vaccine over concerns about patients developing post-jab blood clots, as the manufacturer and the European Medicines Agency insisted the vaccine was safe. The EMA said that information available so far indicated the risk of blood clots in those vaccinated against the coronavirus was "no higher than that seen in the general population." It also said that European countries could keep using the AstraZeneca vaccine while the issue was investigated, concluding that "the vaccine's benefits continue to outweigh its risks". Denmark, the first to announce it was suspending...